Stay updated on Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma
Sign up to get notified when there's something new on the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page.

Latest updates to the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page
- ChecktodayChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2. The study record content remains unchanged.SummaryDifference0.1%

- Check7 days agoChange DetectedThe footer revision label updates from v3.7.0 to v3.7.1, with no change to the clinical trial record history.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history. The previous revision v3.6.6 was removed, indicating a newer system update to the history page.SummaryDifference0.1%

- Check49 days agoChange DetectedNew revision entry Revision: v3.6.6 has been added to the record history, and the previous entry Revision: v3.6.5 has been removed. This updates the history tracking to reflect the latest version of the study record.SummaryDifference0.1%

- Check71 days agoChange DetectedA new revision entry v3.6.5 is added to the record history and the previous v3.6.4 entry is removed, updating the study's version history.SummaryDifference0.1%

- Check85 days agoChange DetectedA new revision entry (v3.6.4) was added to the history, replacing the previous revision (v3.6.3). This indicates a small update to the page's revision history.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page.